Lyell Immunopharma (NASDAQ:LYEL) Upgraded to Hold at Wall Street Zen
Lyell Immunopharma (NASDAQ:LYEL – Get Free Report) was upgraded by equities research analysts at Wall Street Zen to a “hold” rating in a research note issued to investors on Friday. Separately, HC Wainwright reiterated a “neutral” rating and set a $20.00 price target on shares of Lyell Immunopharma in a research report on Wednesday, April […]
Lyell Immunopharma (NASDAQ:LYEL – Get Free Report) was upgraded by equities research analysts at Wall Street Zen to a “hold” rating in a research note issued to investors on Friday. Separately, HC Wainwright reiterated a “neutral” rating and set a $20.00 price target on shares of Lyell Immunopharma in a research report on Wednesday, April […]
